ASAnne J. Spaans

Anne J. Spaans

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anne J. Spaans has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cutting to the Truth: Are We Measuring Osteotomy Parameters Correctly?

    by Corey B. Fuller, Anne J. Spaans, Roel J. H. Custers, Wouter H. Nijhuis, Nienke van Egmond, Ralph J. B. Sakkers, Eva A. Bax

    Purpose: Traditional lower limb deformity analysis in pediatrics and adults centers on the anatomical center of the knee. However, in high tibial osteotomy (HTO) for medial compartment knee osteoarthritis (KOA), the surgical goal is often valgus overcorrection toward a lateral weight-bearing point. This study quantified the effect of using a lateral weight-bearing point versus the center of the knee on lower-limb alignment parameters and assessed how these differences may influence surgical decision-making. Methods: A retrospective radiographic study was conducted in 20 patients with unicompartmental KOA who underwent HTO. Alignment was measured using 2 methods: the anatomical center of the knee and a 62.5% lateral weight-bearing point as the lateral weight-bearing reference point. Measured parameters included the mechanical lateral distal femoral angle (mLDFA), mechanical medial proximal tibial angle (mMPTA), mechanical lateral distal tibial angle (mLDTA), and mechanical hip-knee-ankle angle (mHKAA). Methods were compared using paired t tests. Results: Using a 62.5% lateral weight-bearing point altered all alignment parameters. Compared with knee-centered measurements, mLDFA increased by 1.52° (more varus), mMPTA decreased by 1.84° (more varus), and mLDTA decreased by 1.85° (more valgus) (all P < 0.001). These changes altered deformity classification, with femora classified as varus increasing from 4 to 10 and tibiae from 8 to 13. Conclusion: Using a lateral weight-bearing point for deformity analysis produces predictable changes in alignment measurements that frequently alter deformity classification. This approach may reveal occult femoral deformities underestimated by traditional methods and may provide a more biomechanically relevant framework for osteotomy planning.

  • Open Access

    Effectiveness and limitations of anti-sclerostin therapy in osteogenesis imperfecta: A systematic review

    by Zhiming Wu, Suzanne Den Haan, Faith Perek, Wouter Nijhuis, Harrie Weinans, Ralph Sakkers, Anne Spaans, Kelly Warmink

  • Open Access

    The Role of Bone Marrow Microenvironment in Osteogenesis Imperfecta: Evidence from Single-Cell RNA Sequencing

    by Zhiming Wu, Suzanne Den Haan, Wouter Nijhuis, Claudia Y. Janda, Thanasis Margaritis, Harrie Weinans, Ralph Sakkers, Anne J. Spaans, Kelly Warmink

    INTRODUCTION: Osteogenesis imperfecta (OI) is a genetic disorder primarily due to mutations in collagen type I-encoding genes, resulting in fragile bones, frequent fractures, pain, and mobility issues. Disease severity and phenotype vary widely, even with the same mutation, suggesting the importance of other factors within the bone microenvironment that influence disease severity. To study the role of such factors, we analyzed bone samples from OI patients and healthy controls using single-cell RNA sequencing to reveal if RNA expression profiles may uncover mechanisms behind OI phenotype. METHODS: Bone samples from surgeries of OI patients and healthy individuals isolated and RNA single-cell sequencing was performed, followed by quality control and bioinformatics analysis. Two healthy and three OI patients were included: two with type-I OI, characterized by a mutation in COL1A1 (collagen type I), and another with type-VIII OI, associated with LEPRE1 mutations, which disrupt the 3-hydroxylation of type I collagen. RESULTS: Clustering and differential expression analysis showed distinct subpopulations in mesenchymal and immune cells. In all OI samples, mesenchymal stromal cell (MSC) proportions were reduced compared to healthy controls. OI type-I patients showed decreased osteoblast numbers alongside an increase in osteoclast precursor cells. Whereas in OI type-VIII, all bone turnover-related cells (osteoblast, osteoclast precursor, and osteoclast) were elevated. Notably, BMP5 and RUNX1 were downregulated in MSCs from both OI types. DISCUSSION: This study demonstrates that the bone marrow microenvironment in OI is significantly altered beyond the known collagen defects. Single-cell RNA sequencing revealed reduced MSC numbers and downregulated osteogenic gene expression. Furthermore, alterations are patient-specific: OI type-I is characterized by reduced osteoblast counts, whereas OI type-VIII exhibits increased osteoblasts and osteoclasts. These findings highlight the critical role of impaired osteogenic differentiation and an abnormal bone remodeling environment in the pathology of OI.

  • Open Access

    Histological and molecular characterization of bone integrity in osteogenesis imperfecta: a case series across genetic subtypes

    by Zhiming Wu, Suzanne Den Haan, Helen E King, Wouter H Nijhuis, Harrie Weinans, Anne J Spaans, Ralph Sakkers, Kelly Warmink

    Osteogenesis imperfecta (OI) is a genetically heterogeneous skeletal disorder characterized by bone fragility and variable clinical severity. However, how molecular defects translate into alterations of bone microstructure and composition across OI subtypes remains incompletely understood. In this case series, we systematically evaluated cortical bone integrity in patients with OI types 1, 3, 4, 6, 8, and 14 using histological and molecular approaches, including Raman spectroscopy, and compared findings with non-OI controls. Histological analyses revealed case-specific disruption of bone architecture across OI cases, where the severity of bone disorganization increased progressively from OI type 1 to types 3, 6, 8, and 14. In addition osteocyte lacunar area (Ot.Lc.Ar) was increased specifically in OI subtypes 1, 6, 8, and 14 bones, while osteocyte lacunar appearance was heterogeneous in size, shape, alignment, and spatial distribution in OI types 3, 6, 8, and 14, underscoring the case-specific alterations. Consistently, polarized light microscopy demonstrated increased green birefringence under polarized light microscopy in OI types 1 and 14 and reduced lamellar thickness in OI types 1, 6, and 8. At the molecular level, Raman spectroscopic analyses showed reduced mineral and organic matrix signals in OI bone, specifically OI type 3, indicating compromised mineralization and altered bone matrix composition. Together, these findings illustrate the potential that OI bone phenotype illustrates potential subtype-specific trends in bone microarchitecture, collagen disorganization, impaired lamellar bone formation, and deficits in bone mineral and matrix composition. This integrative analysis links genetic defects in collagen-related and non-collagen genes to multiscale alterations in bone tissue, providing mechanistic insight into OI pathophysiology and highlighting potential structural targets for individualized therapeutic strategies.

  • Open Access

    Linking genetic variants to bone microstructure: Histological signatures of osteogenesis imperfecta subtypes

    by Zhiming Wu, Karlijn Scheepens, Suzanne Den Haan, Wouter Nijhuis, Harrie Weinans, Ralph Sakkers, Anne Spaans, Kelly Warmink

  • Open Access

    Three weeks of indomethacin is not superior to 1 week of meloxicam as prophylaxis for heterotopic ossifications after distal biceps tendon repair with a single-incision technique

    by Elisabeth A. Wörner, Isaak F. Kodde, Anne J. Spaans, Nicola Colic, Nick Hilgersom, Iris van Oost, Bertram The, Denise Eygendaal


  • Joint Distraction for Thumb Carpometacarpal Osteoarthritis: 2-Year Follow-up Results of 20 Patients

    by Janna S.E. Ottenhoff, Anne J. Spaans, Assa Braakenburg, Teun Teunis, L. Paul van Minnen, Aebele B. Mink van der Molen

    Background Joint distraction is a fairly new treatment for patients with symptomatic thumb carpometacarpal osteoarthritis (CMC1 OA). A previous pilot study of five patients showed that CMC1 joint distraction is technically feasible. The current study presents the results of CMC1 joint distraction in 20 patients with a 2-year follow-up period. Purposes The primary study aim was to assess if patients with CMC1 OA have better physical function and less pain 2 years after CMC1 joint distraction. Second, we assessed the number of patients who achieved a minimal clinically important difference (MCID) in patient-reported outcome measures at each follow-up time point. Furthermore, this study sought differences on magnetic resonance imaging (MRI) of the CMC1 joint before and after distraction. Adverse events were noted and reported. Methods Twenty patients (median age of 54 years) with symptomatic CMC1 OA and an established indication for a trapeziectomy were enrolled. An external distractor device was placed over the CMC1 joint and left in situ for 8 weeks. Disabilities of the Arm, Shoulder, and Hand (DASH) score, Michigan Hand Outcome Questionnaire (MHQ), visual analogue scale (VAS), and grip strength were recorded preoperatively and at 3, 6, 12, and 24 months postoperatively. Results Two years after joint distraction, physical function and pain scores had improved significantly compared with baseline: DASH from 48 to 17, MHQ from 56 to 83, and VAS for pain from 50 to 18 mm. Fourteen of 19 patients (74%) reached an MCID in DASH and MHQ scores. One patient was not satisfied with treatment outcome and chose to proceed with a trapeziectomy 14 months after initial distraction therapy. Conclusions This study demonstrates that CMC1 joint distraction can postpone more invasive surgical interventions (e.g., trapeziectomy) for at least 2 years. Larger comparative studies are needed to assess the value of CMC1 joint distraction in the treatment of CMC1 OA. Level of Evidence This is a Level IV, prospective case series study.